Opiant Pharmaceuticals, Inc.
CAGE Code: 73QL8
NCAGE Code: 73QL8
Status: Active
Type: Commercial Supplier
Summary
Opiant Pharmaceuticals, Inc. is an Active Commercial Supplier with the Cage Code 73QL8.
Address
233 Wilshire Blvd Ste 280
Santa Monica CA 90401-1240
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
I D P Villa La Paloma, Llc Century Health Technology, Inc Computer Keyboard Systems Ltd Compuwave Inc Turbo Research Co Moonware Inc Premier Innovations Rush Hour Express Moore Ruble Yudell Mac Solutions Inc Cornell Deep Drawing Co Hastings Plastics Co Pipco International Corp Clinton Laboratories Dnk Media Thermocal Inc Evpassport Holdings Llc The Nettleship Group Inc Meret Optical Communications Inc
Frequently Asked Questions (FAQ) for CAGE 73QL8
- What is CAGE Code 73QL8?
- 73QL8 is the unique identifier used by NATO Organizations to reference the physical entity known as Opiant Pharmaceuticals, Inc. located at 233 Wilshire Blvd Ste 280, Santa Monica CA 90401-1240, United States.
- Who is CAGE Code 73QL8?
- 73QL8 refers to Opiant Pharmaceuticals, Inc. located at 233 Wilshire Blvd Ste 280, Santa Monica CA 90401-1240, United States.
- Where is CAGE Code 73QL8 Located?
- CAGE Code 73QL8 is located in Santa Monica, CA, USA.
Contracting History for CAGE 73QL8 Most Recent 25 Records
- 75A50118D00029
- Opiant: Make The Selection To Ipp Reportable In The Contract Writing System.
- 21 Jul 2022
- Opiant: Make The Selection To Ipp Reportable In The Contract Writing System.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $8,682,528.00
- Department Of Health And Human Services (Hhs)
- 75A50118D00029
- De-Obligate $95,516.40 From Clin 0003 Option 2 For Closeout.
- 2 Jan 2024
- De-Obligate $95,516.40 From Clin 0003 Option 2 For Closeout.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $10,664,588.60
- Department Of Health And Human Services (Hhs)
- 75A50118D00029
- Extend The Period Of Performance For Option 1/Clin 0002 And Increase Funding, Revise The Contracting Officer, And Add Hhsar Clause 352.232-71.
- 18 Jan 2022
- Extend The Period Of Performance For Option 1/Clin 0002 And Increase Funding, Revise The Contracting Officer, And Add Hhsar Clause 352.232-71.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $8,682,528.00
- Department Of Health And Human Services (Hhs)
- 75A50118D00029
- Period Of Performance Extension For Option 1 (Clin 0002) As Well As The Period Of Performance Change (Start Date Delay) For Option 2 (Clin 0003).
- 17 Dec 2021
- Period Of Performance Extension For Option 1 (Clin 0002) As Well As The Period Of Performance Change (Start Date Delay) For Option 2 (Clin 0003).
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $6,471,230.00
- Department Of Health And Human Services (Hhs)
- 75A50118D00029
- Reformulate Nalmefene, An Fda Approved Drug For Opioid Overdose
- 19 Sep 2018
- Reformulate Nalmefene, An Fda Approved Drug For Opioid Overdose
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $10,664,588.60
- Department Of Health And Human Services (Hhs)
- 75A50118D00029
- Revise Sow; Cor Change; And Supplemental Funding
- 25 Oct 2021
- Revise Sow; Cor Change; And Supplemental Funding
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $6,471,230.00
- Department Of Health And Human Services (Hhs)